We are live on ! Find out more
BG

Bahl & Gaynor Portfolio holdings

AUM $19.8B
1-Year Est. Return 19.53%
This Fund
S&P 500
This Quarter Est. Return
-0.12%
1 Year Est. Return
+19.53%
3 Year Est. Return
+63.97%
5 Year Est. Return
+84.2%
10 Year Est. Return
+296.44%
AUM
$6.71B
AUM Growth
+$133M
Cap. Flow
+$178M
Cap. Flow %
2.66%
Top 10 Hldgs %
26.7%
Holding
442
New
38
Increased
200
Reduced
128
Closed
18

Top Buys

Rank Stock Value
1
MMM icon
3M
MMM
+$44.9M
2
HSY icon
Hershey
HSY
+$33.9M
3
VTR icon
Ventas
VTR
+$33.1M
4
PAYX icon
Paychex
PAYX
+$31M
5
PEP icon
PepsiCo
PEP
+$26.1M

Top Sells

Rank Stock Value
1
GSK icon
GSK
GSK
+$54.8M
2
AAPL icon
Apple
AAPL
+$24M
3
O icon
Realty Income
O
+$21.6M
4
CFR icon
Cullen/Frost Bankers
CFR
+$17.6M
5
IBM icon
IBM
IBM
+$8.55M

Sector Composition

Rank Sector Weight
1 Healthcare 16.26%
2 Consumer Staples 15.49%
3 Technology 15.18%
4 Industrials 11.77%
5 Energy 10.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DXJ icon
201
WisdomTree Japan Hedged Equity Fund
DXJ
$7.2B
$1.17M 0.02%
22,270
OZK icon
202
Bank OZK
OZK
$5.7B
$1.16M 0.02%
36,693
-3,720
-9% -$120K
CRR
203
DELISTED
Carbo Ceramics Inc.
CRR
$1.15M 0.02%
19,350
-400
-2% -$45.6K
MAT icon
204
Mattel
MAT
$4.32B
$1.1M 0.02%
35,960
-104,040
-74% -$3.68M
WSO icon
205
Watsco Inc
WSO
$13.8B
$1.09M 0.02%
12,653
+6,255
+98% +$578K
WWW icon
206
Wolverine World Wide
WWW
$1.59B
$1.07M 0.02%
42,831
-3,440
-7% -$88.6K
THO icon
207
Thor Industries
THO
$4.16B
$1.01M 0.02%
19,665
+10,580
+116% +$567K
CBRL icon
208
Cracker Barrel
CBRL
$1.28B
$1.01M 0.02%
+9,775
New +$978K
IEMG icon
209
iShares Core MSCI Emerging Markets ETF
IEMG
$156B
$1M 0.01%
19,985
+2,260
+13% +$120K
CHE icon
210
Chemed
CHE
$7.05B
$971K 0.01%
9,434
HPQ icon
211
HP
HPQ
$26.4B
$957K 0.01%
59,421
+9,689
+19% +$157K
ESRX
212
DELISTED
Express Scripts Holding Company
ESRX
$950K 0.01%
13,447
-366
-3% -$26.1K
VET icon
213
Vermilion Energy
VET
$1.69B
$942K 0.01%
15,495
-475
-3% -$30.4K
KN icon
214
Knowles
KN
$3.45B
$928K 0.01%
35,008
-21,528
-38% -$657K
TBRG
215
DELISTED
TruBridge
TBRG
$928K 0.01%
16,133
+5,445
+51% +$340K
FDS icon
216
Factset
FDS
$9.76B
$907K 0.01%
7,465
-157
-2% -$19.4K
CMD
217
DELISTED
Cantel Medical Corporation
CMD
$891K 0.01%
25,943
+3,345
+15% +$118K
STAG icon
218
STAG Industrial
STAG
$7.28B
$882K 0.01%
42,600
+24,740
+139% +$570K
AAXJ icon
219
iShares MSCI All Country Asia ex Japan ETF
AAXJ
$3.79B
$877K 0.01%
14,299
-1,245
-8% -$80.4K
SLH
220
DELISTED
SOLERA HOLDINGS, INC. COM
SLH
$860K 0.01%
15,265
-200
-1% -$12.7K
PFM icon
221
Invesco Dividend Achievers ETF
PFM
$804M
$856K 0.01%
41,067
-425
-1% -$8.92K
ZTS icon
222
Zoetis
ZTS
$31.9B
$853K 0.01%
23,098
DEM icon
223
WisdomTree Emerging Markets High Dividend Fund
DEM
$3.97B
$850K 0.01%
17,791
-50
-0.3% -$2.6K
EWBC icon
224
East-West Bancorp
EWBC
$18.3B
$850K 0.01%
+25,000
New +$867K
TYPE
225
DELISTED
Monotype Imaging Holdings Inc.
TYPE
$840K 0.01%
+29,635
New +$864K

Similar funds

Bahl & Gaynor's Q3 2014 Portfolio in Review

As of Q3 2014, Bahl & Gaynor held 442 positions worth $6.71B, up 2% from $6.58B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Bahl & Gaynor's Q3 2014 filing shows 38 new, 200 increased, 128 reduced and 18 closed positions. Its largest new stake was Cracker Barrel: 9,775 shares worth $1.01M. The largest sale was GSK, an estimated $54.8M.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, down from 17% a quarter earlier, followed by Consumer Staples and Technology.

  • Bahl & Gaynor's largest Q3 2014 buy was Cracker Barrel: 9,775 shares worth $1.01M.
  • Bahl & Gaynor added most to 3M in Q3 2014, an estimated $44.9M increase.
  • Bahl & Gaynor's biggest Q3 2014 reduction was GSK, cutting an estimated $54.8M.
  • Bahl & Gaynor fully exited GNC Holdings, Inc. in Q3 2014, selling an estimated $2.07M.
  • Bahl & Gaynor's ten largest holdings make up 27% of its $6.71B portfolio in Q3 2014.
  • Bahl & Gaynor opened 38 new positions and closed 18 in Q3 2014.
  • Bahl & Gaynor's portfolio value rose 2% quarter-over-quarter to $6.71B.

Based on Bahl & Gaynor's 13F filing for Q3 2014, filed 12 Nov 2014.